EGFR and cholangiocarcinoma: Previous study of combination treatment of Gefitinib and gemcitabine enhance the cytotoxicity could reduce the protein of ERK phosphorylation and indicated for EGFR signaling suppression in CCA cell (Nakajima et al., 2012).